Compass Therapeutics
Price & Volume
Stats
See moreOpen | $2.44 |
Previous Close | $2.38 |
Day Range | $2.29-$2.44 |
52W Range | $0.76-$4.08 |
Market Cap | $329.1M |
Shares Short | 7M |
Financials
See moreRevenue (12 Mos) | $850,000 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $850,000 |
Diluted EPS | -$0.40 |
News
See moreYahoo Finance • 2 months ago
Compass Therapeutics Announces First Patient Dosed in an Investigator Sponsored Trial of Tovecimig in the First-Line Setting for Patients with Biliary Tract Cancer
Yahoo Finance • 3 months ago
Compass Therapeutics to Participate in the Stifel 2025 Virtual Targeted Oncology Forum
Yahoo Finance • 2 years ago
Compass Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
Yahoo Finance • 2 years ago
Compass Therapeutics to Participate in Upcoming Investor Events
About
CEO | Dr. Thomas J. Schuetz M.D., Ph.D. |
Address | 80 Guest Street, Boston, MA, United States, 02135 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 35 |
